Lulu Zeng

Lulu Zeng

Auto-generated profile, based on publicly available information

Lulu Zeng

Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2026 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
XJXiaojian Ji
Xiaojian Ji
ZLZhuofeng Li
Zhuofeng Li
LZLulu Zeng
Lulu Zeng
LHLidong Hu
Lidong Hu
YWYanyan Wang
Yanyan Wang
KLKunpeng Li
Kunpeng Li
Axial spondyloarthritis (axSpA) is an inflammatory disease marked by chronic low back pain, with a global average diagnostic delay of 6.7 years. Early diagnosis is crucial for improving prognosis and reducing disability rates, yet primary care physicians (PCPs) may find it challenging to ensure timely recognition and referrals. This study developed and validated Spondyloarthritis Agents (SpAgents), an early diagnostic system based on a multi-agent framework integrating large language models (LLMs) and imaging models. The SpAgents framework includes PlannerAgent, DataAgent, ToolAgent, and DoctorAgent, supported by long-term memory for dynamic knowledge updates. We enrolled 596 patients, dividing 545 from one hospital into a training dataset (n = 359) and a validation dataset (n = 186), along with an independent cohort of 51 patients from five additional hospitals for testing. SpAgents demonstrated strong diagnostic performance, achieving sensitivity of 0.8615 and specificity of 0.8000 during validation, and 0.9375 and 0.7368 during testing. SpAgents exhibited significantly higher sensitivity (0.9400) and accuracy (0.8600) than both PCPs and junior rheumatologists, with overall performance equivalent to that of senior rheumatologists. Under SpAgents-assisted diagnosis, both PCPs and junior rheumatologists showed marked improvements in sensitivity and accuracy. SpAgents effectively enhance early axSpA identification among PCPs, offering an innovative solution to reduce diagnostic delays.

17 March 2025 in Rheumatology
Verified
Journal Article
Closed access
YZYinan Zhang
Yinan Zhang
YWYiwen Wang
Yiwen Wang
JHJiawen Hu
Jiawen Hu
XJXiaojian Ji
Xiaojian Ji
XLXingkang Liu
Xingkang Liu
FHFeng Huang
Feng Huang
Objective: To investigate the awareness, implementation and factors influencing physical activity (PA) engagement among Chinese patients with radiographic axial spondyloarthritis (r-axSpA), and their relationships with disease status. Methods: This cross-sectional study enrolled 151 r-axSpA patients and evaluated their awareness of PA while collecting sociodemographic and disease-related parameters. PA levels were assessed with the Godin Leisure-Time Exercise Questionnaire (GLTEQ) and daily steps recorded by smartphones. Influencing factors were evaluated using the Inflammatory arthritis FAcilitators and Barriers (IFAB) questionnaire. Spearman's correlation analysis was used to explore relationships between variables. Results: Among 151 r-axSpA patients, 98.0% were aware of health benefits of PA, and 97.4% reported that physicians had recommended PA to them. However, fewer patients knew the World Health Organization recommendations on aerobic PA (33.8%) and muscle-strengthening activities (33.1%), as well as the European League Against Rheumatism (EULAR) recommendations for PA (55.6%). According to daily steps, only 13.2% were classified as active. Individual exercise (62.3%) was the main form. A sedentary group (GLTEQ score < 14) demonstrated significantly poorer awareness of recommendations and higher disease activity compared with a moderately active/active group (GLTEQ score ≥ 14). Awareness of EULAR recommendations was positively correlated with GLTEQ score (P = 0.003). IFAB6 (lack of motivation, P = 0.015) and IFAB8 (knowledge of benefits of PA, P = 0.045) showed significant differences between the sedentary and the moderately active/active group. Conclusion: Despite recognizing health benefits of PA, patients had limited awareness of PA recommendations and under-engaged in PA. This insufficient awareness correlated with lower activity and worse disease status. Healthcare professionals should enhance PA education and encourage regular PA.

7 July 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
XLXingkang Liu
Xingkang Liu
XJXiaojian Ji
Xiaojian Ji
LHLidong Hu
Lidong Hu
TJTianyu Jiang
Tianyu Jiang
AMAng Min
Ang Min
ZZZheng Zhao
Zheng Zhao
Background: Ankylosing spondylitis (AS), a chronic inflammatory disease, causes spinal stiffness, functional impairment, and reduced quality of life. While exercise is critical for managing AS, traditional home-based programs lack real-time supervision to ensure movement quality and adherence. Emerging digital tools like inertial sensors may address this gap, but their clinical impact remains unproven. Objective: This study aims to evaluate the feasibility and efficacy of a Digital Functional Exercise Program (DFEP) using wearable sensors and real-time feedback for patients with AS. Methods: This single-blind randomized controlled trial (ChiCTR2300068327) enrolled 80 adults with AS from the Chinese People’s Liberation Army (PLA) General Hospital. Participants were randomized 1:1 to: DFEP Group: 24-week sensor-guided exercises via the Healbone Mini Program (Jiakangzhongzhi, Co), with real-time feedback and remote physiotherapist oversight. Control Group: standard home-based exercises with written instructions. The primary outcome is the change in Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) at 24 weeks. Secondary outcomes include Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Assessment of Spondyloarthritis International Society Health Index (ASAS HI), 36-Item Short Form Survey (SF-36), pain visual analog scale, Five-Times-Sit-to-Stand, 4-meter walk test, Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), and adherence. Analyses will follow an intention-to-treat approach with the Last Observation Carried Forward for missing data; continuous variables will be compared with t tests or ANOVA, and categorical variables with chi-square tests, using a 2-sided =.05. Results: We have screened 216 outpatients who may be eligible subjects, among them 126 outpatients who initially met the inclusion criteria. After evaluating clinicians performed face-to-face assessments, 23 lacked a stable medication regimen, 5 presented with severe cervical vertebral bridges, 3 reported regular structured exercise, 2 could not be reached after prescreening, 10 had significant cardiovascular disease, and 3 declined participation due to time constraints. Ultimately, 80 eligible participants were enrolled, with 36 randomly allocated to the intervention group and 44 to the control group. Recruitment (February 2023-March 2024) and follow-up (concluding September 2024) are complete. Data analysis (November 2024) and result dissemination (April 2025) are pending. Conclusions: This trial is the first to test a fully digital, sensor-based exercise program for AS. If effective, DFEP could offer a scalable, cost-effective solution for home rehabilitation in AS and related conditions. Trial Registration: Chinese Clinical Trial Registry ChiCTR2300068327; https://www.chictr.org.cn/showproj.html?proj=190897 International Registered Report Identifier (IRRID): DERR1-10.2196/67556

20 October 2024 in JMIR Preprints
Verified
Preprint
Open access
XLXingkang Liu
Xingkang Liu
XJXiaojian Ji
Xiaojian Ji
LHLidong Hu
Lidong Hu
TJTianyu Jiang
Tianyu Jiang
AMAng Min
Ang Min
ZZZheng Zhao
Zheng Zhao
BACKGROUND Ankylosing spondylitis (AS), a chronic inflammatory disease, causes spinal stiffness, functional impairment, and reduced quality of life. While exercise is critical for managing AS, traditional home-based programs lack real-time supervision to ensure movement quality and adherence. Emerging digital tools like inertial sensors may address this gap, but their clinical impact remains unproven. OBJECTIVE This study aims to evaluate the feasibility and efficacy of a Digital Functional Exercise Program (DFEP) using wearable sensors and real-time feedback for patients with AS. METHODS This single-blind randomized controlled trial (ChiCTR2300068327) enrolled 80 adults with AS from the Chinese People’s Liberation Army (PLA) General Hospital. Participants were randomized 1:1 to: DFEP Group: 24-week sensor-guided exercises via the Healbone Mini Program (Jiakangzhongzhi, Co), with real-time feedback and remote physiotherapist oversight. Control Group: standard home-based exercises with written instructions. The primary outcome is the change in Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) at 24 weeks. Secondary outcomes include Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Metrology Index (BASMI), Assessment of Spondyloarthritis International Society Health Index (ASAS HI), 36-Item Short Form Survey (SF-36), pain visual analog scale, Five-Times-Sit-to-Stand, 4-meter walk test, Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), and adherence. Analyses will follow an intention-to-treat approach with the Last Observation Carried Forward for missing data; continuous variables will be compared with t tests or ANOVA, and categorical variables with chi-square tests, using a 2-sided =.05. RESULTS We have screened 216 outpatients who may be eligible subjects, among them 126 outpatients who initially met the inclusion criteria. After evaluating clinicians performed face-to-face assessments, 23 lacked a stable medication regimen, 5 presented with severe cervical vertebral bridges, 3 reported regular structured exercise, 2 could not be reached after prescreening, 10 had significant cardiovascular disease, and 3 declined participation due to time constraints. Ultimately, 80 eligible participants were enrolled, with 36 randomly allocated to the intervention group and 44 to the control group. Recruitment (February 2023-March 2024) and follow-up (concluding September 2024) are complete. Data analysis (November 2024) and result dissemination (April 2025) are pending. CONCLUSIONS This trial is the first to test a fully digital, sensor-based exercise program for AS. If effective, DFEP could offer a scalable, cost-effective solution for home rehabilitation in AS and related conditions. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR2300068327; https://www.chictr.org.cn/showproj.html?proj=190897 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/67556